X4 Pharmaceuticals
XFOR
XFOR
93 hedge funds and large institutions have $23.6M invested in X4 Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.06% less ownership
Funds ownership: 1.95% → 1.89% (-0.06%)
68% less capital invested
Capital invested by funds: $73.2M → $23.6M (-$49.7M)
Holders
93
Holding in Top 10
–
Calls
$202K
Puts
$31K
Top Buyers
| 1 | +$971K | |
| 2 | +$488K | |
| 3 | +$248K | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$150K |
| 5 |
BlackRock
New York
|
+$87.4K |
Top Sellers
| 1 | -$934K | |
| 2 | -$563K | |
| 3 | -$428K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$250K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$239K |
